Hillman Capital Management reported 54 stock positions (53 companies; some appear in two share classes) worth $138.2M in its 2026 Q2 Form 13F, for the quarter ended Jun 30, 2026, filed Aug 14, 2026. Its largest position is CVS HEALTH Corp (CVS), at 4.15% of the reported portfolio value. Its biggest move versus the previous quarter was in PRICE T ROWE GROUP INC (TROW), where it cut the position by 86.1%.
| Ticker | Company | Weight | Shares | Change |
|---|---|---|---|---|
| CVS | CVS HEALTH Corp | 4.15% | 55,475 | TRIMMED (-17.8%) |
| BIIB | BIOGEN INC. | 3.75% | 23,993 | TRIMMED (-18.8%) |
| DD | DuPont de Nemours, Inc. | 3.71% | 37,745 | TRIMMED (-4.0%) |
| WBD | Warner Bros. Discovery, Inc. | 3.67% | 189,986 | TRIMMED (-3.2%) |
| BAX | BAXTER INTERNATIONAL INC | 3.64% | 236,032 | TRIMMED (-4.6%) |
| IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | 3.61% | 62,875 | TRIMMED (-13.6%) |
| GSK | GSK plc · ADR | 3.51% | 92,383 | TRIMMED (-5.2%) |
| KMX | CARMAX INC | 3.50% | 91,385 | TRIMMED (-16.3%) |
| BA | BOEING CO | 3.38% | 21,574 | TRIMMED (-3.4%) |
| ZBH | ZIMMER BIOMET HOLDINGS, INC. | 3.36% | 53,943 | TRIMMED (-3.2%) |
| KHC | Kraft Heinz Co | 3.36% | 196,494 | TRIMMED (-2.3%) |
| BF.B | BROWN FORMAN CORP | 3.33% | 172,514 | TRIMMED (-2.2%) |
| PFE | PFIZER INC | 3.04% | 174,610 | TRIMMED (-7.1%) |
| EL | ESTEE LAUDER COMPANIES INC | 2.87% | 50,226 | TRIMMED (-3.7%) |
| FISV | FISERV INC | 2.79% | 78,456 | TRIMMED (-2.8%) |
| MSFT | MICROSOFT CORP | 2.78% | 10,296 | TRIMMED (-4.9%) |
| CPB | CAMPBELL'S Co | 2.60% | 161,043 | TRIMMED (-3.1%) |
| ADBE | ADOBE INC. | 2.57% | 17,288 | ADDED (+6.7%) |
| EFA | ISHARES MSCI EAFE ETF | 2.39% | 31,743 | ADDED (+2.9%) |
| NKE | NIKE, Inc. | 2.32% | 78,213 | ADDED (+0.4%) |
| TSM | TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD · ADR | 1.94% | 5,608 | TRIMMED (-29.6%) |
| BMY | BRISTOL MYERS SQUIBB CO | 1.89% | 45,235 | TRIMMED (-14.8%) |
| WST | WEST PHARMACEUTICAL SERVICES INC | 1.85% | 7,106 | TRIMMED (-20.2%) |
| USB | US BANCORP DE | 1.80% | 41,252 | TRIMMED (-21.5%) |
| VEEV | VEEVA SYSTEMS INC | 1.80% | 14,008 | NEW |
| CMCSA | COMCAST CORP | 1.79% | 100,843 | ADDED (+5.9%) |
| DIS | Walt Disney Co | 1.77% | 25,385 | ADDED (+3.2%) |
| CAG | CONAGRA BRANDS INC. | 1.76% | 180,728 | ADDED (+22.4%) |
| VZ | VERIZON COMMUNICATIONS INC | 1.75% | 57,263 | TRIMMED (-11.9%) |
| UPS | UNITED PARCEL SERVICE INC | 1.74% | 22,316 | HELD |
| BDX | BECTON DICKINSON & CO | 1.67% | 15,238 | ADDED (+7.2%) |
| UNH | UNITEDHEALTH GROUP INC | 1.63% | 5,405 | TRIMMED (-27.0%) |
| DEO | DIAGEO PLC · ADR | 1.60% | 27,492 | TRIMMED (-0.1%) |
| STZ | CONSTELLATION BRANDS, INC. | 1.58% | 15,651 | TRIMMED (-16.7%) |
| CRM | Salesforce, Inc. | 1.55% | 13,658 | ADDED (+24.7%) |
| EFX | EQUIFAX INC | 1.44% | 12,541 | TRIMMED (-7.5%) |
| AKAM | AKAMAI TECHNOLOGIES INC | 1.40% | 16,387 | TRIMMED (-28.2%) |
| HSY | HERSHEY CO | 1.35% | 10,608 | HELD |
| ORCL | ORACLE CORP | 1.22% | 11,496 | TRIMMED (-28.6%) |
| IVV | ISHARES CORE S&P 500 ETF | 0.86% | 1,589 | ADDED (+27.1%) |
| MDT | Medtronic plc | 0.32% | 5,707 | ADDED (+55.6%) |
| TROW | PRICE T ROWE GROUP INC | 0.30% | 3,610 | TRIMMED (-86.1%) |
| APD | Air Products & Chemicals, Inc. | 0.28% | 1,306 | TRIMMED (-2.5%) |
| ACN | Accenture plc | 0.28% | 3,055 | NEW |
| TMO | THERMO FISHER SCIENTIFIC INC. | 0.27% | 750 | ADDED (+14.3%) |
| RTX | RTX Corp | 0.27% | 1,935 | TRIMMED (-2.0%) |
| GOOG | Alphabet Inc. | 0.26% | 1,030 | TRIMMED (-8.6%) |
| NOW | ServiceNow, Inc. | 0.25% | 3,415 | ADDED (+1.1%) |
| CLX | CLOROX CO /DE/ | 0.24% | 3,531 | TRIMMED (-0.7%) |
| BLK | BlackRock, Inc. | 0.24% | 343 | TRIMMED (-1.2%) |
| INTU | INTUIT INC. | 0.23% | 1,203 | ADDED (+25.7%) |
| CSGP | COSTAR GROUP, INC. | 0.22% | 10,745 | ADDED (+25.6%) |
| IWR | iShares Russell Mid-Cap ETF | 0.16% | 2,007 | TRIMMED (-18.0%) |
| GOOGL | Alphabet Inc. | <0.01% | 4 | TRIMMED (-33.3%) |
Exited this quarter: BWX, GE, SPYM.
These rows were fully sold in this quarter but have no confirmed U.S. ticker, so they appear here by issuer name exactly as filed, with no stock link. They are counted in "Trimmed / exited" above and nowhere else.
| Issuer (as filed) | Prior-quarter value | Change |
|---|---|---|
| ISHARES TR (464288117) | $230.3K | EXITED Ticker unconfirmed on the issuer's official product page — shown by issuer name only. |
BWX and SPYM are the two SPDR Series Trust rows the fund held in Q1 2026 (CUSIPs 78464A516 and 78464A854) and sold in full in Q2. Their tickers are confirmed on State Street Global Advisors fund pages: BWX and SPYM. SPYM is the current listing for CUSIP 78464A854; the Q1 row dates from the former SPLG share class, so SPLG is not used as the ticker here.
Source: SEC Form 13F filing for the quarter ended Jun 30, 2026, filed Aug 14, 2026. CIK 0001314620. Change labels compare with the fund’s previous quarterly filing. 13F filings cover long positions only and report holdings as of quarter-end; each filing is due within 45 days after quarter-end, so the filing lag above is the gap between quarter-end and this filing’s date, and it varies by when the manager actually filed.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Hypothetical 13F-clone performance — not the fund’s actual returns. The clone holds the long U.S. equity positions disclosed in this manager’s Form 13F filings at their reported weights, rebalanced on filing dates, on dividend-adjusted prices. Full series and the filing-by-filing evidence dossier: 13F-clone profile.
A snapshot at quarter-end, not today’s portfolio: 13F filings arrive up to 45 days late, cover long positions only, and omit cash, shorts, and derivatives. Copying this list also means copying its timing, prices, and position sizes.
Read the original filings at SEC EDGAR.
Not investment advice. Filings are delayed and incomplete.
How we measure: Methodology · Track Record · Q3 2026 13F tracker.
See the same rule applied to every tracked fund, including this one: Follow a Fund — each quarter’s top 5 new and increased positions, bought at the close on the first trading day after the 13F deadline and held for a quarter, scored against SPY.
Compare overlap → Compare your own book against this fund and the other tracked funds.
Mairs & Power Funds · Track Record: how the signals scored · Compare overlap
One email a week: the week’s new filings and research. Subscribe free
← Harding Loevner · Himalaya Capital Management →
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.